Zum Hauptinhalt springen

Press Releases and Ad-hoc Announcements

29. November 2023
AH: Heidelberg Pharma Announces Changes to the Executive Management Board
PDF
15. November 2023
PR: Heidelberg Pharma Secures Patent for the Use of its ADC Technology Platform
PDF
02. November 2023
PR: Heidelberg Pharma Presents New Clinical Data from its Lead Candidate HDP-101 at the ASH Annual Meeting 2023
PDF
12. Oktober 2023
PR: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023
PDF
19. September 2023
PR: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101
PDF
08. August 2023
PR: Heidelberg Pharma’s Partner Takeda Reached Development Milestone
PDF
13. Juli 2023
PR: Heidelberg Pharma Reports on First Half-Year 2023 and the Course of Business
PDF
29. Juni 2023
AH: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics
PDF
25. Mai 2023
PR: Heidelberg Pharma reports on the results of the Annual General Meeting 2023
PDF
05. Mai 2023
PR: Heidelberg Pharma appoints Chief Financial Officer
PDF